| Analysis of differences and commonalities in pricing and reimbursement systems in Europe J Espin, J Rovira Brussels: DG Enterprise and Industry of the European Commission 100, 2007 | 132 | 2007 |
| Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis E Molina-Montes, M Requena, E Sanchez-Cantalejo, MF Fernandez, ... Gynecologic oncology 136 (1), 158-171, 2015 | 121 | 2015 |
| Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: a systematic review and meta-analysis E Molina-Montes, B Pérez-Nevot, M Pollán, E Sánchez-Cantalejo, J Espín, ... The Breast 23 (6), 721-742, 2014 | 113 | 2014 |
| A general framework for classifying costing methods for economic evaluation of health care Z Špacírová, D Epstein, L García-Mochón, J Rovira, A Olry de Labry Lima, ... The European Journal of Health Economics 21 (4), 529-542, 2020 | 112 | 2020 |
| Experiences and impact of European risk-sharing schemes focusing on oncology medicines J Espín, J Rovira, L García Brussels: Commissioned by the European Commission, Directorate-General …, 2011 | 64 | 2011 |
| How can voluntary cross-border collaboration in public procurement improve access to health technologies in Europe J Espín, J Rovira, A Calleja, N Azzopardi-Muscat, E Richardson, W Palm, ... Health systems and policy analysis, policy brief 21, 2016 | 56 | 2016 |
| The impact of biosimilars’ entry in the EU market J Rovira, J Espín, L García, A Olry de Labry Andalusian Sch Pub Health 30, 1-83, 2011 | 54 | 2011 |
| Pharmaceutical pricing and reimbursement information (PPRI)–New PPRI analysis including Spain S Vogler, J Espin, C Habl Pharmaceuticals Policy and Law 11 (3), 213-234, 2009 | 54 | 2009 |
| Pandemic influenza control in Europe and the constraints resulting from incoherent public health laws R Martin, A Conseil, A Longstaff, J Kodo, J Siegert, AM Duguet, ... BMC Public Health 10, 1-10, 2010 | 53 | 2010 |
| Implementing outcomes-based managed entry agreements for rare disease treatments: nusinersen and tisagenlecleucel KM Facey, J Espin, E Kent, A Link, E Nicod, A O’Leary, E Xoxi, ... Pharmacoeconomics 39, 1021-1044, 2021 | 52 | 2021 |
| Esquemas innovadores de mejora del acceso al mercado de nuevas tecnologías: los acuerdos de riesgo compartido J Espín, J Oliva, JM Rodríguez-Barrios Gaceta Sanitaria 24, 491-497, 2010 | 52* | 2010 |
| Multiple criteria decision analysis for HTA across four EU member states: piloting the advance value framework A Angelis, M Linch, G Montibeller, T Molina-Lopez, A Zawada, K Orzel, ... Social Science & Medicine 246, 112595, 2020 | 47 | 2020 |
| Short-and long-term effects of value-based pricing vs. external price referencing P Kanavos, E Nicod, J Espin, S Van Den Aardweg Eminet, LSE, 2010 | 45 | 2010 |
| Projecting pharmaceutical expenditure in EU5 to 2021: adjusting for the impact of discounts and rebates J Espin, M Schlander, B Godman, P Anderson, J Mestre-Ferrandiz, ... Applied health economics and health policy 16 (6), 803-817, 2018 | 42 | 2018 |
| Personalised medicine as a challenge for public pricing and reimbursement authorities–A survey among 27 European countries on the example of trastuzumab C Leopold, S Vogler, C Habl, AK Mantel-Teeuwisse, J Espin Health Policy 113 (3), 313-322, 2013 | 39 | 2013 |
| Working paper 1: External price referencing–review series on pharmaceutical pricing policies and interventions J Espin, J Rovira, AO de Labry Geneva: World Health Organization and Health Action International, 2011 | 38 | 2011 |
| Medicine Prices in Latin American Countries JE Balbino, JR Forns, CV González Medicine Price Surveys, Analyses and Comparisons, 61-83, 2019 | 37* | 2019 |
| Evaluation of new medicines in Spain and comparison with other European countries D Epstein, J Espín Gaceta sanitaria 34, 133-140, 2020 | 35 | 2020 |
| The role of indication-based pricing in future pricing and reimbursement policies: a systematic review V Preckler, J Espín Value in Health 25 (4), 666-675, 2022 | 34 | 2022 |
| HTA and decision-making processes in Central, Eastern and South Eastern Europe: Results from a survey L García-Mochón, JE Balbino, AO de Labry Lima, AC Martinez, EM Ruiz, ... Health Policy 123 (2), 182-190, 2019 | 33 | 2019 |
